See every side of every news story
Published loading...Updated

UAE Approves BioAro's Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health

UNITED ARAB EMIRATES, JUL 8 – BioAro's patent-pending Longevity+ targets healthy aging amid a global market expected to exceed $44 billion by 2030, following UAE approval for wider international rollout.

Summary by Benzinga
CALGARY, Alberta, July 08, 2025 (GLOBE NEWSWIRE) -- In a significant move that bridges biotechnology, preventive health, and global wellness trends, Canadian biotech company BioAro has announced the launch of its first nutraceutical product under its new supplement line: Longevity+™, a patent-pending, scientifically formulated capsule designed to support healthy aging through synergistic multi-molecule integration. With approvals already secured…

10 Articles

All
Left
5
Center
2
Right
2
Globe NewswireGlobe Newswire
+6 Reposted by 6 other sources
Center

UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health

UAE Approves BioAro’s Longevity+ Supplement, unlocking major global market potential in preventive health and personalized wellness solutions....

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 56% of the sources lean Left
56% Left
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Hamilton Spectator broke the news in Hamilton, Canada on Tuesday, July 8, 2025.
Sources are mostly out of (0)